Biopharma, a biopharmaceutical company based in Kyiv, plans to triple the number of its plasma centers to 30 by 2027, according to the company’s president Konstantin Efimenko.
“We plan to increase the number of plasma centers. Currently, there are 10 of them, but by 2027 we want to increase their number to 30,” he said during the forum “Dialogues on Sustainability. How Business Develops in Times of War” forum in Kyiv on Thursday.
He also said that since the beginning of the full-scale invasion, the company “has not stopped working for almost a single day.”
In particular, in March 2022, Biopharma built a complex of diesel generator stations with a total capacity of 2 mW and purchased four 10 cubic meters of fuel tanks, built bomb shelters at the plant and in its office in Kyiv.
As reported, in 2020, Biopharma announced plans to invest $20-23 million in the development of a network of plasma centers by 2025 and build plasma and blood centers in every regional center of Ukraine.
Biopharma, a blood products maker, intends by the end of 2018 to open two plasma centers in Kharkiv and one in Dnipro, it is also planned to build a center in Cherkasy, President of Biopharma Kostiantyn Yefymenko has told Interfax-Ukraine. “Now we are engaged in the construction of two plasma centers in Kharkiv. We have already rented premises with an area of 700 square meters and plan to rent another facility with an area of 1,500 square meters. We are also planning to build one more center in Dnipro, where we have already rented premises (733 sq m) and Cherkasy. In time, we will build in other regional centers,” he said.
Yefymenko said that at present conceptual projects, construction projects have been approved for plasma centers in Kharkiv and the Dnipro, permissions have been obtained and dismantling work commenced.
“We plan to launch our first center in Kharkiv in autumn, in Dnipro in December,” he noted.
Biopharma, which currently collects about 4 tonnes of blood plasma per month, expects that the opening of new plasma centers in the first quarter of 2019 will increase the amount of plasma collection to 20 tonnes a month. Biopharma is one of the ten largest Ukrainian producers of medicines. It produces more than 20 immunobiological preparations from donor blood, preparations obtained by recombinant DNA technology and probiotics.
